First Trust Capital Management’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-847,315
Closed -$8.38M 452
2022
Q2
$8.38M Buy
847,315
+749,915
+770% +$7.42M 0.59% 32
2022
Q1
$964K Buy
+97,400
New +$960K 0.1% 151

Other funds holding PROK

First Trust Capital Management's PROK Position: Q3 2022 in Review

First Trust Capital Management sold out of ProKidney (PROK) in Q3 2022, closing a stake of 847,315 shares — an estimated $8.38M sold.

First Trust Capital Management first reported a position in PROK in Q1 2022 and held it in 2 quarters. The position peaked at $8.38M in Q2 2022. 18 funds tracked by Wall St. Rank hold PROK as of Q3 2022.

  • First Trust Capital Management reported no remaining ProKidney position as of Q3 2022 after selling out during the quarter.
  • First Trust Capital Management sold 847,315 ProKidney shares in Q3 2022, an estimated $8.38M.
  • First Trust Capital Management first reported a position in ProKidney in Q1 2022 and held it in 2 quarters.
  • First Trust Capital Management's ProKidney position peaked at $8.38M in Q2 2022.
  • 18 funds tracked by Wall St. Rank held ProKidney as of Q3 2022.

Based on First Trust Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.